IMP3 can predict aggressive behaviour of lung adenocarcinoma

Overview of attention for article published in Diagnostic Pathology, November 2012

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

patent: 9 patents

facebook: 1 Facebook page

Citations

dimensions_citation: 34 Dimensions

Readers on

mendeley: 15 Mendeley

Summary Patents Facebook Dimensions citations

So far, Altmetric has seen 9 patents that reference this research output.

PERSONALIZED IMMUNOTHERAPY AGAINST SEVERAL NEURONAL AND BRAIN TUMORS

Application EP-4253401-A2

European Patent Office

NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER INCLUDING NSCLC

Application EP-3616707-A1

European Patent Office

NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER INCLUDING NSCLC

Application EP-3616710-A1

European Patent Office

NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER INCLUDING NSCLC

Application EP-3616711-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 5 additional patents.